Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Adjunctive immunotherapy with α-crystallin based DNA vaccination reduces Tuberculosis chemotherapy period in chronically infected mice.

Chauhan P, Jain R, Dey B, Tyagi AK.

Sci Rep. 2013;3:1821. doi: 10.1038/srep01821.

PMID:
23660989
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A booster vaccine expressing a latency-associated antigen augments BCG induced immunity and confers enhanced protection against tuberculosis.

Dey B, Jain R, Gupta UD, Katoch VM, Ramanathan VD, Tyagi AK.

PLoS One. 2011;6(8):e23360. doi: 10.1371/journal.pone.0023360. Epub 2011 Aug 17.

PMID:
21858087
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis.

Ha SJ, Jeon BY, Kim SC, Kim DJ, Song MK, Sung YC, Cho SN.

Gene Ther. 2003 Sep;10(18):1592-9.

PMID:
12907951
[PubMed - indexed for MEDLINE]
4.

Protective effect of DNA vaccine during chemotherapy on reactivation and reinfection of Mycobacterium tuberculosis.

Ha SJ, Jeon BY, Youn JI, Kim SC, Cho SN, Sung YC.

Gene Ther. 2005 Apr;12(7):634-8.

PMID:
15690060
[PubMed - indexed for MEDLINE]
5.

Immunogenicity and therapeutic effects of Ag85A/B chimeric DNA vaccine in mice infected with Mycobacterium tuberculosis.

Liang Y, Wu X, Zhang J, Xiao L, Yang Y, Bai X, Yu Q, Li Z, Bi L, Li N, Wu X.

FEMS Immunol Med Microbiol. 2012 Dec;66(3):419-26. doi: 10.1111/1574-695X.12008.

PMID:
23163873
[PubMed - indexed for MEDLINE]
6.

Efficient tuberculosis treatment in mice using chemotherapy and immunotherapy with the combined DNA vaccine encoding Ag85B, MPT-64 and MPT-83.

Yu DH, Hu XD, Cai H.

Gene Ther. 2008 May;15(9):652-9. doi: 10.1038/gt.2008.13. Epub 2008 Feb 21.

PMID:
18288210
[PubMed - indexed for MEDLINE]
7.

Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice.

Silva CL, Bonato VL, Coelho-Castelo AA, De Souza AO, Santos SA, Lima KM, Faccioli LH, Rodrigues JM.

Gene Ther. 2005 Feb;12(3):281-7.

PMID:
15526006
[PubMed - indexed for MEDLINE]
8.

[Recent progress in mycobacteriology].

Okada M, Kobayashi K.

Kekkaku. 2007 Oct;82(10):783-99. Japanese.

PMID:
18018602
[PubMed - indexed for MEDLINE]
9.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
[PubMed - indexed for MEDLINE]
10.

Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis.

Cardona PJ, Amat I, Gordillo S, Arcos V, Guirado E, Díaz J, Vilaplana C, Tapia G, Ausina V.

Vaccine. 2005 Feb 3;23(11):1393-8.

PMID:
15661388
[PubMed - indexed for MEDLINE]
11.

Direct comparison of low-dose and Cornell-like models of chronic and reactivation tuberculosis in genetically susceptible I/St and resistant B6 mice.

Radaeva TV, Nikonenko BV, Mischenko VV, Averbakh MM Jr, Apt AS.

Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):65-72. Epub 2004 Dec 31.

PMID:
15687029
[PubMed - indexed for MEDLINE]
12.

[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.

PMID:
17240920
[PubMed - indexed for MEDLINE]
13.

Incorporation of immunostimulatory motifs in the transcribed region of a plasmid DNA vaccine enhances Th1 immune responses and therapeutic effect against Mycobacterium tuberculosis in mice.

Wu J, Ma H, Qu Q, Zhou WJ, Luo YP, Thangaraj H, Lowrie DB, Fan XY.

Vaccine. 2011 Oct 13;29(44):7624-30. doi: 10.1016/j.vaccine.2011.08.020. Epub 2011 Aug 19.

PMID:
21856352
[PubMed - indexed for MEDLINE]
14.

Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tuberculosis-infected mice.

Bonato VL, Lima VM, Tascon RE, Lowrie DB, Silva CL.

Infect Immun. 1998 Jan;66(1):169-75.

PMID:
9423854
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Treatment of multi-drug-resistant tuberculosis in mice with DNA vaccines alone or in combination with chemotherapeutic drugs.

Liang Y, Wu X, Zhang J, Yang Y, Wang L, Bai X, Yu Q, Li N, Li Z.

Scand J Immunol. 2011 Jul;74(1):42-6. doi: 10.1111/j.1365-3083.2011.02538.x.

PMID:
21352251
[PubMed - indexed for MEDLINE]
16.
17.

The immunogenicity and protective efficacy of Mtb8.4/hIL-12 chimeric gene vaccine.

Li H, Li R, Zhong S, Ren H, Zou Y, Chen X, Shi X, Wang M, Long H, Luo Y.

Vaccine. 2006 Feb 27;24(9):1315-23. Epub 2005 Sep 27.

PMID:
16219397
[PubMed - indexed for MEDLINE]
18.

Mycobacterium indicus pranii as stand-alone or adjunct immunotherapeutic in treatment of experimental animal tuberculosis.

Faujdar J, Gupta P, Natrajan M, Das R, Chauhan DS, Katoch VM, Gupta UD.

Indian J Med Res. 2011 Nov;134(5):696-703. doi: 10.4103/0971-5916.90999.

PMID:
22199110
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Latency antigen α-crystallin based vaccination imparts a robust protection against TB by modulating the dynamics of pulmonary cytokines.

Dey B, Jain R, Khera A, Gupta UD, Katoch VM, Ramanathan VD, Tyagi AK.

PLoS One. 2011 Apr 18;6(4):e18773. doi: 10.1371/journal.pone.0018773.

PMID:
21533158
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Elicitation of efficient, protective immune responses by using DNA vaccines against tuberculosis.

Khera A, Singh R, Shakila H, Rao V, Dhar N, Narayanan PR, Parmasivan CN, Ramanathan VD, Tyagi AK.

Vaccine. 2005 Dec 1;23(48-49):5655-65. Epub 2005 Aug 1.

PMID:
16157425
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk